- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
September 24th, 2007
Preserving organs and killing cancer cells with products that employ nanotechnology—the emerging science of manufacturing at the molecular level—were the hot topics last week when the New Jersey Technology Council sponsored a forum on one of the latest trends in biomedical research.
The Philadelphia gathering of 25 executives, scientists and other members of the health care community heard how nanotechnology is being used to make and develop biomedical devices and drugs. The science, which takes place on the scale of one billionth of a meter, is slowly leaving federally funded laboratories and making its way into fields ranging from retail to medicine.
Panelist Joseph Fischer, chairman and CEO of Lifeblood Medical Inc. in Adelphia, says his company employs nanotechnology to make Lifor, a liquid that preserves organs used for transplants, and to make LiforCell, which preserves tissues and cells used in laboratory experiments. He says the U.S. Navy is testing Lifor for limb preservation.
|Related News Press|
Glitter from silver lights up Alzheimer's dark secrets August 25th, 2015
Cervical cancer detection goes portable August 25th, 2015
Antibacterial Nanocomposite Prevents Transmission of Infectious Diseases August 24th, 2015
Successful boron-doping of graphene nanoribbon August 27th, 2015
Nanolab Technologies LEAPS Forward with High-Performance Analysis Services to the World: Nanolab Orders Advanced Local Electrode Atom Probe (LEAP®) Microscope from CAMECA Unit of AMETEK Materials Analysis Division August 27th, 2015
Nanometrics to Participate in the Citi 2015 Global Technology Conference August 26th, 2015
Developing Component Scale Composites Using Nanocarbons August 26th, 2015